Searched over 200M research papers
10 papers analyzed
These studies suggest that remission in cancer can involve both spontaneous and treatment-induced remission, with spontaneous remission being rare and potentially influenced by immune responses, psychological factors, and complete tumor resection.
20 papers analyzed
Cancer remission refers to a state where the signs and symptoms of cancer are reduced or disappear. This can be either complete or partial. In complete remission, all signs of cancer are gone, while in partial remission, some, but not all, signs and symptoms of cancer have disappeared .
Complete remission is characterized by the total disappearance of all detectable cancer. This can occur spontaneously or as a result of treatment. For instance, a case study reported a patient with metastatic non-small-cell lung cancer (NSCLC) who achieved complete spontaneous remission without any active therapy . Another study highlighted that complete remission in advanced NSCLC could be achieved through multiple lines of chemotherapy combined with surgery or radiation to control primary and oligometastatic tumors.
Spontaneous remission (SR) is an exceptionally rare phenomenon where cancer regresses without any medical intervention or with treatment that is not expected to cause such a significant effect. This has been documented in various cancers, including lung cancer, where cases of SR have been linked to immune responses or other biological mechanisms . For example, one study reported a patient with NSCLC who experienced SR after adjuvant immunotherapy, potentially due to a strong immune response involving CD8+ T cells.
Psychological and psychosocial factors may play a role in spontaneous remission. Some theories suggest that mental and emotional states could influence the immune system's ability to fight cancer, although this area requires more empirical research to avoid speculative conclusions.
Biological mechanisms, such as immune responses, are often cited in cases of spontaneous remission. For instance, the presence of anti-NY-ESO-1 immunity has been associated with SR in lung cancer patients, indicating that specific immune responses might contribute to the regression of tumors.
Effective communication between healthcare providers and cancer survivors is crucial for managing remission. Survivors often experience a range of physical and psychological symptoms, including anxiety and fear of recurrence, which need to be addressed through patient-centered care and support.
Patients in remission require long-term monitoring to detect any signs of recurrence. Studies have shown that even after achieving complete remission, there is a significant risk of relapse, particularly in metastatic cancers like breast cancer. Therefore, ongoing surveillance and possibly consolidation treatments are essential to prolong remission and improve quality of life.
Remission in cancer, whether complete or spontaneous, represents a significant milestone in a patient's journey. Understanding the factors that contribute to remission and providing comprehensive support and monitoring can help improve outcomes for cancer survivors. While spontaneous remission remains a rare and poorly understood phenomenon, ongoing research into its mechanisms may offer new insights into cancer treatment and survivorship.
Most relevant research papers on this topic